We anticipate that rapid, robust, and inexpensive detection of MHC antigen–specific T cells will have a strong impact on the immune monitoring of responses to infection and cancer immunotherapies, as well as vaccines (Bentzen et al., 2016; El Bissati et al., 2016; Grassmann et al., 2017; La Rosa et al., 2017). Here, HLA-C is linked to infection.